海辰药业
(300584)
| 流通市值：15.96亿 | | | 总市值：23.33亿 |
| 流通股本：8211.86万 | | | 总股本：1.20亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 360,497,824.16 | 236,532,812.43 | 104,561,855.22 | 517,832,192 |
| 营业收入 | 360,497,824.16 | 236,532,812.43 | 104,561,855.22 | 517,832,192 |
| 二、营业总成本 | 324,027,907.82 | 205,032,329.98 | 85,582,384.45 | 475,390,505.12 |
| 营业成本 | 60,911,488.02 | 37,517,295.31 | 18,677,772.39 | 96,594,643.93 |
| 税金及附加 | 7,940,032.54 | 5,362,618.8 | 2,415,960.22 | 11,292,529.73 |
| 销售费用 | 150,433,501.51 | 95,581,574.02 | 38,595,773.27 | 241,595,638.54 |
| 管理费用 | 63,620,585.66 | 42,283,430.43 | 18,419,917.88 | 71,915,662.18 |
| 研发费用 | 34,268,297.38 | 19,738,113.2 | 5,429,812.44 | 46,634,035.48 |
| 财务费用 | 6,854,002.71 | 4,549,298.22 | 2,043,148.25 | 7,357,995.26 |
| 其中:利息费用 | 6,820,431.18 | 4,590,276.92 | 2,071,727.45 | 8,272,643.27 |
| 其中:利息收入 | 94,120.82 | 73,474.85 | 44,881.08 | 960,836.68 |
| 加:公允价值变动收益 | 1,705.87 | - | - | 64,178.97 |
| 加:投资收益 | -120,412.6 | -28,020.77 | -105 | -24,372.12 |
| 资产处置收益 | -52,414.95 | -25,197.5 | - | -791,829.47 |
| 资产减值损失(新) | -6,808,591.63 | -4,389,932.75 | -3,118,633.22 | -4,681,304.37 |
| 信用减值损失(新) | 1,189,426.54 | 813,949.88 | 206,023.07 | -1,676,994.6 |
| 其他收益 | 681,467.03 | 460,081.92 | 268,517.26 | 3,961,183.25 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 31,361,096.6 | 28,331,363.23 | 16,335,272.88 | 39,292,548.54 |
| 加:营业外收入 | 24,264.04 | 11,485.48 | 150.2 | 239,830.43 |
| 减:营业外支出 | 1,175,224.66 | 957,651.07 | 62,150.32 | 1,843,095.43 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 30,210,135.98 | 27,385,197.64 | 16,273,272.76 | 37,689,283.54 |
| 减:所得税费用 | 2,093,329.35 | 2,648,848.71 | 2,915,459.32 | 1,373,729.47 |
| 六、净利润 | 28,116,806.63 | 24,736,348.93 | 13,357,813.44 | 36,315,554.07 |
| 持续经营净利润 | 28,116,806.63 | 24,736,348.93 | 13,357,813.44 | 36,315,554.07 |
| 归属于母公司股东的净利润 | 28,116,806.63 | 24,736,348.93 | 13,357,813.44 | 36,315,554.07 |
| (一)基本每股收益 | 0.23 | 0.21 | 0.11 | 0.3 |
| (二)稀释每股收益 | 0.23 | 0.21 | 0.11 | 0.3 |
| 九、综合收益总额 | 28,116,806.63 | 24,736,348.93 | 13,357,813.44 | 36,315,554.07 |
| 归属于母公司股东的综合收益总额 | 28,116,806.63 | 24,736,348.93 | 13,357,813.44 | 36,315,554.07 |
| 公告日期 | 2024-10-26 | 2024-08-23 | 2024-04-25 | 2024-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |